Omada Health reported third-quarter 2026 total revenue of $91,306 thousand, up 34% from $68,030 thousand a year earlier. Operating income was $4,820 thousand, compared with a loss of $(2,513) thousand, and net income was $6,551 thousand versus a net loss of $(3,178) thousand. Total members reached 1,134,000 as of September 30, 2026.
OMDA · Omada Health, Inc.
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Price & Indicators
Key stats
- Short volume, last session
- 39%
- Last earnings
- Nov 5, 2026
- Latest filing
- 10-Q · Nov 6
- Price history
- Jun 2025 to Nov 2026
Up next
Latest documents
Omada Health raised its full-year 2026 revenue outlook to $344 million to $346 million and adjusted EBITDA guidance to $32 million to $34 million, after Q3 revenue rose 34% to $91 million and net income reached nearly $7 million.
Omada Health reported third-quarter revenue of $91 million, up 34%, and 1.1 million Total Members, up 36%. It raised 2026 revenue guidance to $344 million to $346 million and Adjusted EBITDA guidance to $32 million to $34 million.
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
AI Brief
Q3 FY26 earnings call · Nov 5, 2026TL;DR. Omada raised full-year revenue and adjusted EBITDA guidance after Q3 delivered 34% revenue growth, 36% member growth, record profitability, higher margins, and approximately $243 million of cash with no debt. The outlook includes lower Q4 revenue, a slight Q4 membership step-down, and moderating adjusted EBITDA, while GLP-1 coverage uncertainty, rising healthcare costs, and customer concentration remain risks.
- + Reduced non-GAAP cost of revenue per total member to an all-time low of $81, down from $85 in Q2 and $94 in Q3 2025.
- − Expects Q4 revenue to be below Q3 because of lower new enrollment and engagement activity during the holidays.
- − Expects Q4 adjusted EBITDA to moderate from Q3 as R&D and care-team staffing increase for the 2027 benefit launch.
- − GAAP operating expenses increased to 71% of revenue from 70% a year earlier.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | 24.1M | nine months ended September 30, 2026 | — |
|
|
|||
| Free Cash Flow non-GAAP | 2.46M | nine months ended September 30, 2026 | — |
| Non-GAAP gross margin non-GAAP | 78% | third quarter | — |
|
|
|||
| Non-GAAP gross margin (as a percentage of revenue) non-GAAP | 73% | nine months ended September 30, 2026 | — |
| Non-GAAP gross profit non-GAAP | 186.53M | nine months ended September 30, 2026 | — |
|
|
|||
| Total Members | 1.1M | third quarter 2026 | — |
| Trailing 12-month revenue per Total Member | $294 | trailing 12-month period ended September 30, 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
OMDA
this stock
Omada Health, Inc.
|
$736.39M | -24.8% | +53.2% | — | 14.8% |
|
VEEV
Veeva Systems Inc
|
$43.10B | +19.3% | +28.1% | 43.6 | 2.4% |
|
PMDIY
Pro Medicus Ltd.
|
$14.81B | -14.6% | — | — | 0.0% |
|
BTSG
BrightSpring Health Services, Inc.
|
$12.50B | +67.8% | +28.2% | 34.2 | 5.8% |
|
TEM
Tempus AI, Inc.
|
$9.86B | -8.5% | +83.4% | — | 13.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- Filed
- Nov 6, 2026
- This year
- 16
Omada Health reported third-quarter 2026 total revenue of $91,306 thousand, up 34% from $68,030 thousand a year earlier. Operating income was $4,820 thousand, compared with a loss of $(2,513) thousand, and net income was $6,551 thousand versus a net loss of $(3,178) thousand. Total members reached 1,134,000 as of September 30, 2026.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| OMDA | -17.2% | -37.4% | -33.3% | -36.6% | -24.8% |
| SPY | -8.6% | -9.2% | -9.2% | -8.7% | +1.2% |
| vs SPY | -8.6% | -28.1% | -24.1% | -27.9% | -25.9% |